Orange Book product
ARIXTRA 5MG/0.4ML (5MG/0.4ML)
Orange Book NDA 021345 · MYLAN IRELAND LTD · Prescription
Key facts
| Proprietary name | ARIXTRA |
|---|---|
| Active ingredients | FONDAPARINUX SODIUM |
| Strength | 5MG/0.4ML (5MG/0.4ML) |
| Dosage form | SOLUTION |
| Route | SUBCUTANEOUS |
| Application | NDA021345 |
| Applicant holder | MYLAN IRELAND LTD |
| Marketing status | Prescription |
| Therapeutic equivalence (TE) code | AP |
| Reference listed drug (RLD) | Yes |
| Reference standard (RS) | Yes |
| Approval date | May 28, 2004 |
At a glance
- 1–9 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- Yes Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.